Bialkowski Jacek, Szkutnik Malgorzata, Kusa Jacek, Stein Joerg
Congenital Heart Disease & Pediatric Cardiology Department, Silesian Center for Heart Disease, Zabrze, Poland.
Tex Heart Inst J. 2003;30(3):236-9.
Transcatheter closure of patent ductus arteriosus is routinely performed using various devices. After the withdrawal of the Rashkind umbrella device from the market, the wide window-type patent ductus arteriosus has been difficult to close percutaneously. Two patients with this condition are presented: a 17-year-old man and a 62-year-old woman with short (4.5- and 5.2-mm-diameter, respectively) ductus. We successfully implanted a 17-mm CardioSEAL device in the 1st patient and a 23-mm STARFlex in the 2nd, with no residual shunt at follow-up (22 and 8 months, respectively). Although these devices (which follow the general design of the Rashkind umbrella) are usually applied to atrial septal defect closure, we believe that CardioSEAL and STARFlex implants could be the treatment of choice in percutaneous treatment.of window-type patent ductus arteriosus.
经导管闭合动脉导管未闭通常使用各种装置来进行。在Rashkind伞装置退出市场后，宽窗型动脉导管未闭经皮闭合变得困难。本文介绍了两名患有这种情况的患者：一名17岁男性和一名62岁女性，其动脉导管较短（直径分别为4.5毫米和5.2毫米）。我们在第一名患者中成功植入了一个17毫米的CardioSEAL装置，在第二名患者中成功植入了一个23毫米的STARFlex装置，随访时（分别为22个月和8个月）均无残余分流。尽管这些装置（遵循Rashkind伞的一般设计）通常用于闭合房间隔缺损，但我们认为CardioSEAL和STARFlex植入物可能是经皮治疗窗型动脉导管未闭的首选治疗方法。
